A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)

Publisher DOI
PubMed ID
21593661
Abstract
Efavirenz (EFV) causes neuropsychiatric side-effects and an unfavorable blood lipid profile. We investigated the effect of replacing EFV with raltegravir (RAL) on patient preference, daytime sleepiness, sleep quality, anxiety, and lipid levels.
Date Issued
2011
Publication Type
Article
Language(s)
en
Author(s)
Nguyen, Alain
Calmy, Alexandra
Delhumeau, Cecile
Mercier, Isabelle
Cavassini, Matthias
Mello, Aurelie F
Elzi, Luigia
Bernasconi, Enos
Schmid, Patrick
Hirschel, Bernard
Additional Credits
Journal
AIDS
Publisher
Lippincott Williams & Wilkins
ISSN
0269-9370
Access(Rights)
Unknown
Show full item